M. Okazaki

993 total citations
34 papers, 778 citations indexed

About

M. Okazaki is a scholar working on Molecular Biology, Physiology and Plant Science. According to data from OpenAlex, M. Okazaki has authored 34 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Physiology and 6 papers in Plant Science. Recurrent topics in M. Okazaki's work include Chronic Lymphocytic Leukemia Research (5 papers), Asthma and respiratory diseases (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). M. Okazaki is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Asthma and respiratory diseases (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). M. Okazaki collaborates with scholars based in Japan, United States and Belgium. M. Okazaki's co-authors include Hiroshi Ezura, Kosuke Dodo, Mikiko Sodeoka, Yohei Saito, Miwako Asanuma, Yoshiteru Noutoshi, Ken Shirasu, Yoshihiro Shiraiwa, Daisuke Shibata and Takumi Ogawa and has published in prestigious journals such as Blood, The Plant Cell and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

M. Okazaki

30 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Okazaki Japan 13 382 293 170 58 51 34 778
Warren P. Lubich United States 10 85 0.2× 577 2.0× 17 0.1× 20 0.3× 13 0.3× 12 740
Xiaoqian Xue China 12 149 0.4× 391 1.3× 26 0.2× 70 1.2× 59 1.2× 16 686
Ang Gao China 16 215 0.6× 400 1.4× 5 0.0× 78 1.3× 20 0.4× 42 756
Takeshi Mizuno Japan 17 65 0.2× 763 2.6× 17 0.1× 24 0.4× 20 0.4× 41 950
Gary B. Rosenberg United States 14 39 0.1× 426 1.5× 18 0.1× 27 0.5× 53 1.0× 15 640
Mireille Pidoux Switzerland 7 34 0.1× 338 1.2× 21 0.1× 38 0.7× 32 0.6× 8 589
Hildegard I. D. Mack Germany 10 28 0.1× 266 0.9× 38 0.2× 7 0.1× 24 0.5× 18 511
Igor Mačinković Germany 9 27 0.1× 272 0.9× 48 0.3× 44 0.8× 45 0.9× 16 516
Marina Marani Italy 11 20 0.1× 439 1.5× 104 0.6× 18 0.3× 32 0.6× 12 656
Hongyan Du United States 20 51 0.1× 537 1.8× 9 0.1× 104 1.8× 38 0.7× 39 899

Countries citing papers authored by M. Okazaki

Since Specialization
Citations

This map shows the geographic impact of M. Okazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Okazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Okazaki more than expected).

Fields of papers citing papers by M. Okazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Okazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Okazaki. The network helps show where M. Okazaki may publish in the future.

Co-authorship network of co-authors of M. Okazaki

This figure shows the co-authorship network connecting the top 25 collaborators of M. Okazaki. A scholar is included among the top collaborators of M. Okazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Okazaki. M. Okazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasuoka, Hidekata, Yuko Waseda, Yuko Kaneko, et al.. (2025). Treatment patterns and clinical profile in progressive pulmonary fibrosis: a Japanese cross-sectional survey. Frontiers in Medicine. 11. 1526531–1526531.
2.
Hayama, Koremasa, et al.. (2024). The Disease Burdens of Self-diagnosed Hidradenitis Suppurativa Patients in Japan: A Cross-sectional Web-based Survey. Acta Dermato Venereologica. 104. adv32746–adv32746. 1 indexed citations
3.
Hayashi, Nobukazu, Koremasa Hayama, Kenzo Takahashi, et al.. (2023). Real‐world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: A 52‐week analysis of a postmarketing surveillance study in Japan. The Journal of Dermatology. 50(8). 1034–1044. 3 indexed citations
4.
Hayashi, Nobukazu, Koremasa Hayama, Kenzo Takahashi, et al.. (2022). Real‐world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12‐week interim analysis of post‐marketing surveillance in Japan. The Journal of Dermatology. 49(4). 411–421. 8 indexed citations
5.
Okazaki, M., et al.. (2018). Real-World Treatment Patterns for Golimumab and Concomitant Medications in Japanese Rheumatoid Arthritis Patients. Rheumatology and Therapy. 5(1). 185–201. 10 indexed citations
6.
7.
Nakayama, Masahiko, et al.. (2018). Patient Preferences and Urologist Judgments on Prostate Cancer Therapy in Japan. American Journal of Men s Health. 12(4). 1094–1101. 13 indexed citations
8.
Okazaki, M., Tsuyoshi Oikawa, & Takeshi Sugaya. (2015). The biomarker for CKD: urinary L-FABP ― from molecular function to clinical significance. Folia Pharmacologica Japonica. 146(1). 27–32. 2 indexed citations
9.
Okazaki, M., et al.. (2015). VDAC3 gating is activated by suppression of disulfide-bond formation between the N-terminal region and the bottom of the pore. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(12). 3188–3196. 61 indexed citations
10.
Noutoshi, Yoshiteru, M. Okazaki, & Ken Shirasu. (2012). Imprimatins A and B. Plant Signaling & Behavior. 7(12). 1715–1717. 10 indexed citations
11.
Noutoshi, Yoshiteru, M. Okazaki, & Ken Shirasu. (2012). Isolation and characterization of the plant immune-priming compounds Imprimatin B3 and -B4, potentiators of disease resistance inArabidopsis thaliana. Plant Signaling & Behavior. 7(12). 1526–1528. 9 indexed citations
12.
Okazaki, M., et al.. (2010). Lowering intercellular melatonin levels by transgenic analysis of indoleamine 2,3-dioxygenase from rice in tomato plants. Journal of Pineal Research. 49(3). 239–247. 84 indexed citations
13.
14.
Okazaki, M. & Hiroshi Ezura. (2009). Profiling of melatonin in the model tomato (Solanum lycopersicum L.) cultivar Micro‐Tom. Journal of Pineal Research. 46(3). 338–343. 120 indexed citations
15.
Ookawara, Tomomi, et al.. (2000). Serum extracellular superoxide dismutase in pediatric patients with various diseases as judged by an ELISA.. PubMed. 107(3-4). 291–6. 6 indexed citations
16.
Ishida, Tadashi, Toru Hashimoto, Machiko Arita, et al.. (1999). Multicenter Screening of Chlamydia pneumoniae Pneumonia by ELISA Method. Kansenshogaku zasshi. 73(1). 70–75. 1 indexed citations
17.
Yoshida, M., et al.. (1994). Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.. PubMed. 54(10). 2688–94. 25 indexed citations
18.
Yokota, Sandra J., M. Okazaki, Minoru Yoshida, & Ben K. Seon. (1993). Biodistribution and in vivo antitumor efficacy of the systemically administered anti-human T-leukemia immunotoxins and potentiation of their efficacy by α-interferon. Leukemia Research. 17(1). 69–79. 4 indexed citations
19.
20.
Tsubota, T, Yuro Haruta, Kiyoshi Kataoka, et al.. (1984). Production of a macromomycin (MCR)-monoclonal antibody conjugate and its biological activity.. PubMed. 38(2). 117–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Warren P. Lubich Breakdown of academic impact, for papers by Xiaoqian Xue Breakdown of academic impact, for papers by Ang Gao Breakdown of academic impact, for papers by Takeshi Mizuno Breakdown of academic impact, for papers by Gary B. Rosenberg Breakdown of academic impact, for papers by Mireille Pidoux Breakdown of academic impact, for papers by Hildegard I. D. Mack Breakdown of academic impact, for papers by Igor Mačinković Breakdown of academic impact, for papers by Marina Marani Breakdown of academic impact, for papers by Hongyan Du
Rankless by CCL
2026